Register-based studies of cancer screening effects

Scandinavian Journal of Public Health

Volumn 39, Issue 7, 2011, Pages 158-164

  Von Euler Chelpin, My ^a   Lynge, Elsebeth ^a   Rebolj, Matejka ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Breast cancer; cervical cancer; Denmark; registers; review; screening

Indexed keywords

ARTICLE; BREAST TUMOR; DENMARK; FEMALE; HEALTH CARE QUALITY; HUMAN; MAMMOGRAPHY; MASS SCREENING; METHODOLOGY; OUTCOME ASSESSMENT; REGISTER; STANDARD; UTERINE CERVIX TUMOR; VAGINA SMEAR;

BREAST NEOPLASMS; DENMARK; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; OUTCOME ASSESSMENT (HEALTH CARE); PROGRAM EVALUATION; REGISTRIES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 79960785051     PISSN: 14034948     EISSN: 16511905     Source Type: Journal    
DOI: 10.1177/1403494811401479     Document Type: Review

References (40)

1. Advisory Committee on Cancer Prevention. Recommendations on cancer screening in the European Union. Eur J Cancer 2000 ; 36 (12). 1473-8.
2. European Commission. European guidelines for quality assurance in cervical cancer screening, 2 nd ed Luxembourg: Office for Official Publications of the European Communities ; 2008.
3. European Commission. European guidelines for quality assurance in breast cancer screening and diagnosis, 4 th ed Luxembourg: Office for Official Publications of the European Communities ; 2006.
4. Olsen AH, Njor SH, Vejborg I., Schwartz W., Dalgaard P., Jensen MB, et al. Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. BMJ 2005 ; 330 (7485). 220.
5. Gjerstorff ML The Danish Cancer Registry. Scand J Public Health 2011 ; 39 (Suppl 7). 42-5.
6. Helweg-Larsen K. The Danish Register of Causes of Death. Scand J Public Health 2011 ; 39 (Suppl 7). 26-9.
7. Pedersen BP The Danish Civil Registration System. Scand J Public Health 2011 ; 39 (Suppl 7). 22-5.
8. Olsen AH, Njor SH, Lynge E. Estimating the benefits of mammography screening: the impact of study design. Epidemiology 2007 ; 18 (4). 487-92. (Pubitemid 46955316)
9. Jorgensen KJ, Zahl PH, Gotzsche PC Breast cancer mortality in organised mammography screening in Denmark: comparative study. BMJ 2010 ; 340: c1241.
10. Lynge E. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group. APMIS Suppl 1998 ; 83: 1-44.
11. Njor SH, Olsen AH, Bellstrom T., Dyreborg U., Bak M., Axelsson C., et al. Mammography screening in the county of Fyn. November 1993-December 1999. APMIS Suppl 2003 ;(110). 1-33.
12. von Euler-Chelpin M., Olsen AH, Njor S., Vejborg I., Schwartz W., Lynge E. Women's patterns of participation in mammography screening in Denmark. Eur J Epidemiol 2006 ; 21 (3). 203-9.
13. von Euler-Chelpin M., Olsen AH, Njor S., Vejborg I., Schwartz W., Lynge E. Socio-demographic determinants of participation in mammography screening. Int J Cancer 2008 ; 122 (2). 418-23. (Pubitemid 350234730)
14. von Euler-Chelpin M., Olsen AH, Njor S., Jensen A., Vejborg I., Schwartz W., et al. Does educational level determine screening participation ? Eur J Cancer Prev 2008 ; 17 (3). 273-8. (Pubitemid 351549669)
15. Vejborg I., Olsen AH, Jensen MB, Rank F., Tange UB, Lynge E. Early outcome of mammography screening in Copenhagen 1991-99. J Med Screen 2002 ; 9 (3). 115-9. (Pubitemid 35205233)
16. Bihrmann K., Jensen A., Olsen AH, Njor S., Schwartz W., Vejborg I., et al. Performance of systematic and non-systematic ("opportunistic") screening mammography: a comparative study from Denmark. J Med Screen 2008 ; 15 (1). 23-6. (Pubitemid 351629542)
17. Jorgensen KJ, Zahl PH, Gotzsche PC Overdiagnosis in organised mammography screening in Denmark. A comparative study. BMC Womens Health 2009 ; 9: 36.
18. Olsen AH, Agbaje OF, Myles JP, Lynge E., Duffy SW Overdiagnosis, sojourn time, and sensitivity in the Copenhagen mammography screening program. Breast J 2006 ; 12 (4). 338-42. (Pubitemid 43989978)
19. Svendsen AL, Olsen AH, von Euler-Chelpin M., Lynge E. Breast cancer incidence after the introduction of mammography screening: what should be expected? Cancer 2006 ; 106 (9). 1883-90. (Pubitemid 43673202)
20. Andersen SB, Vejborg I., von Euler-Chelpin M. Participation behaviour following a false positive test in the Copenhagen mammography screening programme. Acta Oncol 2008 ; 47 (4). 550-5. (Pubitemid 351878440)
21. Anttila A., Ronco G. Description of the national situation of cervical cancer screening in the member states of the European Union. Eur J Cancer 2009 ; 45 (15). 2685-708.
22. Hakama M. Trends in the incidence of cervical cancer in the Nordic countries. In: Magnus K, editor. Trends in cancer incidence. Washington: Hemisphere ; 1982. pp. 279-92.
23. Lynge E., Poll P. Incidence of cervical cancer following negative smear. A cohort study from Maribo County, Denmark. Am J Epidemiol 1986 ; 124 (3). 345-52. (Pubitemid 16047350)
24. Bray F., Loos AH, McCarron P., Weiderpass E., Arbyn M., Moller H., et al. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Cancer Epidemiol Biomarkers Prev 2005 ; 14 (3). 677-86. (Pubitemid 40489214)
25. Gustafsson L., Ponten J., Zack M., Adami HO International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control 1997 ; 8 (5). 755-63. (Pubitemid 27404646)
26. Kyndi M., Frederiksen K., Kruger KS Cervical cancer incidence in Denmark over six decades (1943-2002). Acta Obstet Gynecol Scand 2006 ; 85 (1). 106-11. (Pubitemid 43879131)
27. Läärä E., Day NE, Hakama M. Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet 1987 ; 1 (8544). 1247-9. (Pubitemid 17070815)
28. Lynge E., Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health 2011 ; 39 (Suppl 7). 30-3.
29. Hakama M., Miller AB, Day NE Screening for cancer of the uterine cervix. Lyon: International Agency for Research on Cancer ; 1986.
30. Bjerregaard B., Larsen OB The Danish Pathology Register. Scand J Public Health 2011 ; 39 (Suppl 7). 72-4.
31. Lynge E., Poll P., Larsen J., Schultz H., Thommesen N. [Screening for uterine cervix cancer in Storstrom, Vestsjaelland and Bornholm counties during 1979-1989]. Ugeskr Laeger 1992 ; 154 (19). 1335-8.
32. Anttila A., von KL, Aasmaa A., Fender M., Patnick J., Rebolj M., et al. Cervical cancer screening policies and coverage in Europe. Eur J Cancer 2009 ; 45 (15). 2649-58.
33. National Board of Health. [Cervical cancer screening guidelines 2007, in Danish]. Copenhagen: National Board of Health. Available from: http://www.sst.dk/publ/Publ2007/PLAN/Kraeft/Anbef-screen-livmoderhals.pdf [ 2007 ].
34. Ronco G., van BM, Becker N., Chil A., Fender M., Giubilato P., et al. Process performance of cervical screening programmes in Europe. Eur J Cancer 2009 ; 45 (15). 2659-70.
35. Lynge E., Poll P., Larsen J., Schultz HB, Thommesen N. [Frequency and follow-up of non-negative cervical smears in the counties of Storstrom, Vestsjaelland and Bornholm in 1979-1989]. Ugeskr Laeger 1993 ; 155 (4). 240-5.
36. Knudsen A., Nielsen K., Sandahl P., Andersen ES [Long-term follow-up of women with first-time diagnosis of mild dysplasia detected by cytological examination of the cervix]. Ugeskr Laeger 2003 ; 165 (21). 2183-7. (Pubitemid 38089428)
37. Kristensen J., Langhoff-Roos J., Kristensen FB, Wittrup M., Bock JE [Increased risk of preterm delivery in women with earlier conization]. Ugeskr Laeger 1994 ; 156 (24). 3632-5.
38. Noehr B., Jensen A., Frederiksen K., Tabor A., Kjaer SK Depth of cervical cone removed by loop electrosurgical excision procedure and subsequent risk of spontaneous preterm delivery. Obstet Gynecol 2009 ; 114 (6). 1232-8.
39. Noehr B., Jensen A., Frederiksen K., Tabor A., Kjaer SK Loop electrosurgical excision of the cervix and subsequent risk for spontaneous preterm delivery: a population-based study of singleton deliveries during a 9-year period. Am J Obstet Gynecol 2009 ; 201 (1). 33-6.
40. Kjaer S., Hogdall E., Frederiksen K., Munk C., van den Brule A., Svare E., et al. The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period. Cancer Res 2006 ; 66 (21). 10630-6. (Pubitemid 44799787)